Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Neuberger Berman Municipal Fund	NBH	21. nov 2024	10.68	+0.09
Neuberger Berman Next Generation Connectivity Fund	NBXG	21. nov 2024	13.15	+0.92
Neuberger Berman Real Estate Securities Income Fund	NRO	21. nov 2024	3.80	+0.66
NeueHealth	NEUE	21. nov 2024	5.07	+2.32
Neumora Therapeutics	NMRA	21. nov 2024	9.69	-1.02
Neuraxis	NRXS	21. nov 2024	3.13	-1.77
Neurobo Pharmaceuticals	NRBO	21. nov 2024	2.35	-2.08
Neurocrine Biosciences	NBIX	21. nov 2024	125.00	+1.39
Neurogene	NGNE	21. nov 2024	15.59	+1.70
NeuroMetrix	NURO	21. nov 2024	4.15	-4.38
Neuronetics	STIM	21. nov 2024	0.84	+4.10
NeuroOne	NMTC	21. nov 2024	0.70	-3.98
Neuropace	NPCE	21. nov 2024	9.00	-2.07
NeuroSense Therapeutics	NRSN	21. nov 2024	0.92	-7.08
Nevro	NVRO	21. nov 2024	4.36	+3.07
New America High Income Fund	HYB	21. nov 2024	8.26	-0.24
New Concept Energy	GBR	21. nov 2024	1.20	+2.01
New England Realty Associates LP Unit A	NEN	21. nov 2024	82.49	0.00
New Fortress Energy A	NFE	21. nov 2024	9.51	+3.59
New Found Gold	NFGC	21. nov 2024	1.62	-1.82
New Germany Fund	GF	21. nov 2024	7.97	-0.99
New Gold	NGD	21. nov 2024	2.88	+3.60
New Horizon Aircraft	HOVR	21. nov 2024	0.47	-3.93
New Mountain Finance Corp	NMFC	21. nov 2024	11.53	+0.09
New Oriental Education & Technology Group ADR	EDU	21. nov 2024	57.71	+1.75
New Pacific Metals	NEWP	21. nov 2024	1.53	-1.92
New Providence Acquisition II A	NPAB	21. nov 2024	11.30	0.00
New Providence Acquisition II Unit	NPABU	21. nov 2024	12.20	0.00
New Residential Investment A Pref	RITM-A	21. nov 2024	25.48	+0.35
New Residential Investment B Pref	RITM-B	21. nov 2024	25.29	+0.04

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.